The interaction of H19 with the EZH2-centered regulation has been previously demonstrated in bladder carcinoma, where a mechanism analogous to the one hypothesized in this paper was proposed [4], and in ERα-positive breast cancer, contributing to chemoresistance [42]. The gene discussed is EZH2; the disease is breast cancer.